Appointed the new Board of Directors

On 27 Sept 2016 in Amsterdam, the VPHi General Assembly has nominated the new Board of Directors for the upcoming year.
VPHi BoD 2017

12 organisations now form the Board of Directors and will be driving the Institute in 2017:

    1. INRIA, represented by Dominique Chapelle
    2. Norwegian University of Science and Technology, represented by Stig Omholt
    3. Saarland University, represented by Norbert Graf
    4. University of Auckland, represented by Peter Hunter
    5. University College London, represented by Vanessa Diaz
    6. University of Sheffield, represented by Rod Hose
    7. Ospedale Pediatrico Bambino Gesù, represented by Marcello Chinali and Edwin Morley Fletcher
    8. Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), represented by Tomas Salas
    9. Great Ormond Street Hospital, represented by Andrew Taylor
    10. University College Dublin, represented by Walter Kolch
    11. Swansea University, represented by Perumal Nithiarasu
    12. Luxembourg Centre for Systems Biomedicine (LCSB), Rudi BALLING

While the first seven in the list are established supporting members, we are happy to announce that over the year we have gained the support of five new organisations with different backgrounds: a regulatory agency, a pediatric hospital, an important U.K. based university, and two research centers focused on System Medicine.

Since the establishment of the Institute, this is the first time VPHi has such a large Board of Directors, confirming the increased importance in silico medicine research has reached.

More information can be found here.

Gallery:

VPHi BoD 2017
Date: 06/10/2016 | Tag: | News: 514 of 1626
All news

News

  • 05/11/2024

    "In silico trials: an updated SWOT Analysis" released by In Silico World

    • The document comprehensively examines the strengths, weaknesses, opportunities, and threats for In Silico Trials in healthcare, providing a roadmap to help biomedical companies navigate and adopt these innovative methodologies. -Read more-
  • 31/10/2024

    In the literature: October 2024 highlights

    • Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter! -Read more-
  • 31/10/2024

    Joint motion for a resolution to revise the Medical Devices Regulation

    • The European Parliament has voted with a large majority to urge the European Commission to implement critical amendments to the EU Medical Device Regulation (MDR) by the first quarter of 2025. The drive for reform is intended to tackle pressing issues in the regulation, which has been criticised for its excessive bureaucracy and impact on patient care, jobs, and innovation in the medical device sector. -Read more-
  • 31/10/2024

    EU Budget for 2025 Prioritizes Research, Health, Education, and Climate Action

    • The European Parliament has presented their draft budget demanding an EU budget for 2025 that focuses on improving people's lives, boosting competitiveness, and addressing current challenges. MEPs are proposing a budget of nearly €201 billion, which exceeds the European Commission's initial proposal of around €199.76 billion. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO